Nicholas Virca
Vorstandsvorsitzender bei Hedgepath LLC
Vermögen: 663 291 $ am 30.04.2024
Aktive Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Samuel Sears | M | 80 | 6 Jahre | |
| Frank O'Donnell | M | 74 | 6 Jahre | |
| James McNulty | M | 73 | 2 Jahre | |
| Niraj Vasisht | M | 61 | 2 Jahre | |
| Amy M. McCord | M | - | 5 Jahre | |
| Wayne Hewitt | M | - | 19 Jahre |
Beziehungs-Chart
Beziehungen zu mehreren Unternehmen
Ehemalige Beziehungen
| Name | Geschlecht | Alter | Unternehmensverbindungen | Zusammenarbeit |
|---|---|---|---|---|
| Garrison Hasara | M | 54 | 9 Jahre | |
| Warren C. Lau | M | 70 |
Mast Therapeutics, Inc.
 Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 5 Jahre |
| Evan Levine | M | 59 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 6 Jahre |
| William Mark Watson | M | 73 | 8 Jahre | |
| Mike M. Goldberg | M | 65 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
| Marcus Wilson | M | 69 | 8 Jahre | |
| Michelle Yanez | F | 52 | 1 Jahre | |
| E. Brendan Magrab | M | 58 | 3 Jahre | |
| Sandra Marino | F | 54 | 6 Jahre | |
| Dennis Longstreet | M | 79 | 9 Jahre | |
| Debra A. Peattie | M | 70 | 3 Jahre | |
| Richard Ono | M | 71 | 8 Jahre | |
| Robert D. Martin | M | 77 | 6 Jahre | |
| Cheryl Grisé | F | 71 | 8 Jahre | |
| Easwaran Sundaram | M | 53 | 6 Jahre | |
| Andrew Leslie Denver | M | 75 | 3 Jahre | |
| Yonesy Núñez | M | - | 4 Jahre | |
| Tammy L. Renner | F | - | - | |
| John Joseph Salerno | M | 68 |
Cytiva US LLC
 Cytiva US LLC BiotechnologyHealth Technology Part of Danaher Corp., Cytiva US LLC is a company that specializes in aerospace filtration technology. The company is based in Marlborough, MA. The company push the limits of what's possible to enable the next generation of air travel. | - |
| Gregory Scheessele | M | 64 | 8 Jahre | |
| Stefan J. Cross | M | 51 | 8 Jahre | |
| Mark Joseph Cantwell | M | 54 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
| Michael Stromer | M | - | 6 Jahre | |
| M. Ross Johnson | M | 79 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 5 Jahre |
| Harold B. Baker | M | 74 | 4 Jahre | |
| Francis B. Moschella | M | - | 6 Jahre | |
| James D. Watson | M | 96 | 19 Jahre | |
| Linda DeLukey Villa | F | 74 | - | |
| Joan M. Robbins | M | 63 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | - |
| Steven M. Plumb | M | 64 |
Mast Therapeutics, Inc.
Mast Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Mast Therapeutics, Inc. is a biopharmaceutical company, which engages in developing novel therapies for serious or life-threatening diseases with significant unmet needs. It leveraging Molecular Adhesion and Sealant Technology, platform, derived from over two decades of clinical, nonclinical, and manufacturing experience with purified and non-purified poloxamers to develop vepoloxamer, which also known as MST-188. The company was founded by Warren C. Lau in December 1995 and is headquartered in San Diego, CA. | 4 Jahre |
| Mark Watson | M | 74 | 8 Jahre |
Statistik
| Land | Beziehungen | % des Gesamten |
|---|---|---|
| Vereinigte Staaten | 37 | 100,00% |
Alter der Beziehungen
Aktive
Vergangene
Herr
Frau
Aufsichtsräte
Führungskräfte
Ursprung der Beziehungen
- Börse
- Insiders
- Nicholas Virca
- Persönliches Netzwerk
